Special Issue of the Journal of Pharmaceutical Sciences Dedicated to Professor Gordon Amidon
A special edition of the Journal of Pharmaceutical Sciences was recently dedicated to Professor Gordon Amidon. The edition honors his many contributions to the pharmaceutical sciences, particularly in oral drug absorption. Gordon Amidon, PhD, Charles R. Walgreen Jr. Professor of Pharmacy and Pharmaceutical Sciences, is best known for his establishment of the Biopharmaceutics Classification System (BCS), which is currently in use by the U.S. Food and Drug Administration, as well as internationally, for classification and regulation of pharmaceuticals.
“The interest and enthusiasm to contribute to the Gordon L. Amidon Dedicated Issue clearly demonstrate the respect and the admiration that the pharmaceutical sciences community has for Professor Amidon’s research contributions, his longstanding commitment to teaching the next generation of pharmacy students, graduate students, postdoctoral fellows and visiting scholars, his dedication to mentoring young scientists, and his dedication to professional service in the pharmaceutical sciences,” notes Dr. Ronald Borchardt, Editor-in-Chief, Journal of Pharmaceutical Sciences.
“Professor Amidon’s contributions to research and education in the pharmaceutical sciences are extraordinary and far reaching,” explains James Dalton, PhD, Dean and Professor of Pharmaceutical Sciences. “This special issue is a fitting tribute to the people and science that he has influenced over the years. As stated in the introductory editorial to the issue, Professor Amidon is indeed among the ‘TRUE GIANTS’ in the pharmaceutical sciences. The College is proud to claim him as an alumnus, faculty colleague, mentor, and friend!”
Gordon Amidon earned his MA in mathematics and his PhD in pharmaceutical chemistry from the University of Michigan. His research group has developed approaches for predicting drug absorption in humans prior to human studies. Besides assisting greatly in the design and development of new drugs, this approach provides a basis for setting rational in vitro standards for drug development and approval.